MS imaging: New technology provides new opportunities

Using Mass Spectrometry for Drug Metabolism Studies

Volumn , Issue , 2004, Pages 305-328

  Reyzer, Michelle L ^a   Caprioli, Richard M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870162965     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (71)

1. 11C]SDZ GLC 756, Synapse, 30, 341, 1998.
2. 11C]raclopride binding in primate brains, Neuropharmacology, 38, 331, 1999.
3. Saleem, A. et al. Modulation of fluorouracil tissue pharmacokinetics by eniluracil: In-vivo imaging of drug action, Lancet, 355, 2125, 2000.
4. Moresco, R.M. et al. PET in psychopharmacology, Pharmacol. Res., 44(3), 151, 2001.
5. 11C]n-methylspiperone, Nucl. Med. Biol., 29, 307, 2002.
6. 76Br]A-69024: A non-benzazepine radioligand for studies of dopamine Di receptors using PET, Nucl. Med. Biol., 29, 295, 2002.
7. Aboagye, E.O. and Price, P.M., Use of positron emission tomography in anticancer drug development, Invest. New Drugs, 21, 169, 2003.
8. Singh, M. and Waluch, V., Physics and instrumentation for imaging in-vivo drug distribution, Adv. Drug Delivery Rev., 41, 7, 2000.
9. Port, R.E. and Wolf, W., Noninvasive methods to study drug distribution, Invest. New Drugs, 21, 157, 2003.
10. Faas, H. et al. Monitoring the intragastric distribution of a colloidal drug carrier model by magnetic resonance imaging, Pharm. Res., 18(4), 460, 2001.
11. 87Rb MRI study, NMR Biomed., 15, 348, 2002.
12. Noworolski, S.M. et al. High spatial resolution H-MRSI and segmented MRI of cortical gray matter and subcortical white matter in three regions of the human brain, Magnet. Reson. Med., 41, 21, 1999.
13. 2 receptor subtypes, Neuroscience, 76(2), 467, 1997.
14. Goldberg, I.E. et al. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain, J. Pharmacol. Exp. Ther., 286(2), 1007, 1998.
15. Johansson, M. et al. Distribution of estramustine in the BT4C rat glioma model, Cancer Chemother. Pharm., 41, 317, 1998.
16. 3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: Influence of withdrawal period, Synapse, 40, 137, 2001.
17. 3 agonist 7-OH-DPAT (7-hydroxy-dipropylaminotetralin) and antipsychotic drugs measured ex vivo by quantitative autoradiography, Can. J. Physiol. Pharm., 78, 7, 2000.
18. Li, C. et al. Biodistribution of paclitaxel and poly(l-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor, Cancer Chemother. Pharm., 46, 416, 2000.
19. 3 receptors in the rat brain: A quantitative autoradiographic study, Histochem. J., 28, 791, 1996.
20. Schotte, A. et al. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding, Psychopharmacology, 124, 57, 1996.
21. Solon, E.G. and Kraus, L., Quantitative whole-body autoradiography in the pharmaceutical industry: Survey results on study design, methods, and regulatory compliance, J. Pharmacol. Toxicol., 46, 73, 2002.
22. Coe, R.A.J., Quantitative whole-body autoradiography, Regul. Toxicol. Pharm., 31, S1, 2000.
23. Langlois, X. et al. Use of the beta-imager for rapid ex vivo autoradiography exemplified with central nervous system penetrating neurokinin 3 antagonists, J. Pharmacol. Exp. Ther., 299(2), 712, 2001.
24. Tribollet, E. et al. Localization and quantitation of tritiated compounds in tissue sections with a gaseous detector of beta particles: Comparison with film autoradiography, Proc. Natl. Acad. Sci., 88, 1466, 1991.
25. Charpak, G., Dominik, W., and Zaganidis, N., Optical imaging of the spatial distribution of beta-particles emerging from surfaces, Proc. Natl. Acad. Sci., 86, 1741, 1989.
26. Lees, J.E. et al. An MCP-based system for beta autoradiography, IEEE Trans. Nucl. Sci., 46(3), 636, 1999.
27. 14C autoradiography, IEEE Trans. Nucl. Sci., 45(3), 1288, 1998.
28. Pacholski, M.L. and Winograd, N., Imaging with mass spectrometry, Chem. Rev., 99, 2977, 1999.
29. Pacholski, M.L. et al. Static time-of-flight secondary ion mass spectrometry imaging of freeze-fractured, frozen-hydrated biological membranes, Rapid Commun. Mass Spectrom., 12, 1232, 1998.
30. Audinot, J.-N. et al. Detection and quantification of benzodiazepines in hair by TOF-SIMS: Preliminary results, Appl. Surf. Sci., 203-204, 718, 2003.
31. Winograd, N., Prospects for imaging TOF-SIMS: From fundamentals to biotechnology, Appl. Surf. Sci., 203-204, 13, 2003.
32. Guerquin-Kern, J.-L. et al. Complementary advantages of fluorescence and SIMS microscopies in the study of cellular localization of two new antitumor drugs, Microsc. Res. Techniq., 36, 287, 1997.
33. Chandra, S., Lorey II, D.R., and Smith, D.R., Quantitative subcellular secondary ion mass spectrometry (SIMS) imaging of boron-10 and boron-11 isotopes in the same cell delivered by two combined BNCT drugs: In vitro studies on human glioblastoma T98G cells, Radiat. Res., 157, 700, 2002.
34. Bennett, B.D. et al. Subcellular localization of p-boronophenylalanine-delivered boron-10 in the rat 9L gliosarcoma: Cryogenic preparation in vitro and in vivo, Radiat. Res., 140, 72, 1994.
35. Fragu, P. and Kahn, E., Secondary ion mass spectrometry (SIMS) microscopy: A new tool for pharmacological studies in humans, Microsc. Res. Techniq., 36, 296, 1997.
36. Todd, P.J. et al. Organic ion imaging of biological tissue with secondary ion mass spectrometry and matrix-assisted laser desorption/ionization, J. Mass Spectrom., 36, 355, 2001.
37. McCandlish, C.A., McMahon, J.M., and Todd, P.J., Secondary ion images of the rodent brain, J. Am. Soc. Mass Spectrom., 11, 191, 2000.
38. Todd, P.J. et al. Organic SIMS of biologic tissue, Anal. Chem., 69, 529A, 1997.
39. 10B from p-boronophenylalanine in a brain tumor model for boron neutron capture therapy, Cancer Res., 56, 4302, 1996.
40. 60+ ion gun for static SIMS and chemical imaging, Appl. Surf. Sci., 203-204, 219, 2003.
41. Karas, M. et al. Matrix-assisted ultraviolet laser desorption of non-volatile compounds, Int. J. Mass Spectrom. Ion Proc., 78, 53, 1987.
42. Karas, M. and Hillenkamp, F., Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons, Anal. Chem., 60(20), 2299, 1988.
43. Li, L., Garden, R.W., and Sweedler, J.V., Single-cell MALDI: A new tool for direct peptide profiling, Trends Biotechnol., 18(4), 151, 2000.
44. Caprioli, R.M., Farmer, T.B., and Gile, J., Molecular imaging of biological samples: Localization of peptides and proteins using MALDI-TOF MS, Anal. Chem, 69(23), 4751, 1997.
45. Chaurand, P., Stoeckli, M., and Caprioli, R.M., Direct profiling of proteins in biological tissue sections by MALDI mass spectrometry, Anal. Chem., 71(23), 5263, 1999.
46. Dreisewerd, K. et al. Direct mass spectrometric peptide profiling and sequencing of nervous tissues to identify peptides involved in male copulatory behavior in Lymnaea stagnalis, Int. J. Mass Spectrom. Ion Proc., 169/170, 291, 1997.
47. Garden, R.W. et al. Excess salt removal with matrix rinsing: Direct peptide profiling of neurons from marine invertebrates using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, J. Mass Spectrom., 31(10), 1126, 1996.
48. Palmer-Toy, D.E. et al. Direct acquisition of matrix-assisted laser desorption/ionization time-of-flight mass spectra from laser capture microdissected tissues, Clin. Chem., 46(9), 1513, 2000.
49. Redeker, V. et al. Combination of peptide profiling by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and immunodetection on single glands or cells, Anal. Chem., 70(9), 1805, 1998.
50. Stoeckli, M. et al. Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues, Nature Med., 7(4), 493, 2001.
51. Troendle, F.J., Reddick, C.D., and Yost, R.A., Detection of pharmaceutical compounds in tissue by matrix-assisted laser desorption/ionization and laser desorption/chemical ionization tandem mass spectrometry with a quadrupole ion trap, J. Am. Soc. Mass Spectrom., 10, 1315, 1999.
52. van Veelen, P.A. et al. Direct peptide profiling of single neurons by matrix-assisted laser desorption-ionization mass spectrometry, Org. Mass Spectrom., 28(12), 1542, 1993.
53. Chaurand, P. et al. Profiling and imaging proteins in the mouse epididymis by imaging mass spectrometry, Proteomics, 3(11), 2221, 2003.
54. Reyzer, M.L. et al. Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry, J. Mass Spectrom., 38(10), 1081, 2003.
55. Spengler, B. and Hubert, M., Scanning microprobe matrix-assisted laser desorption ionization (SMALDI) mass spectrometry: Instrumentation for sub-micrometer resolved LDI and MALDI surface analysis, J. Am. Soc. Mass Spectrom., 13, 735, 2002.
56. Berkenkamp, S. et al. Performance of infrared matrix-assisted laser desorption/ionization mass spectrometry with lasers emitting in the 3 mm wavelength range, Rapid Commun. Mass Spectrom., 11, 1399, 1997.
57. Menzel, C., Berkenkamp, S., and Hillenkamp, F., Infrared matrix-assisted laser desorption/ionization mass spectrometry with a transversely excited atmospheric pressure carbon dioxide laser at 10.6 mm wavelength with static and delayed ion extraction, Rapid Commun. Mass Spectrom., 13, 26, 1999.
58. Schwartz, S.A., Reyzer, M.L., and Caprioli, R.M., Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: Practical aspects of sample preparation, J. Mass Spectrom., 38(7), 699, 2003.
59. Krutchinsky, A.N. and Chait, B.T., On the nature of chemical noise in MALDI mass spectra, J. Am. Soc. Mass Spectrom., 13, 129, 2002.
60. Ayorinde, F.O. et al. Use of meso-tetrakis(pentafluorophenyl)porphyrin as a matrix for low molecular weight alkylphenol ethoxylates in laser desorption/ionization time-of-flight mass spectrometry, Rapid Commun. Mass Spectrom., 13, 2474, 1999.
61. Jones, R.M., Lamb, J.H., and Lim, C.K., 5,10,15,20-meso-tetra(hydroxyphenyl)-chlorin as a matrix for the analysis of low molecular weight compounds by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, Rapid Commun. Mass Spectrom., 9(10), 968, 1995.
62. 60-assisted laser-desorption-ionization-time-of-flight mass spectrometry, J. Anal. Toxicol., 23, 337, 1999.
63. Kinumi, T. et al. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using an inorganic particle matrix for small molecule analysis, J. Mass Spectrom., 35, 417, 2000.
64. Zhang, Q. et al. Matrix-assisted laser desorption/ionization mass spectrometry using porous silicon and silica gel as matrix, Rapid Commun. Mass Spectrom., 15, 217, 2001.
65. Shen, Z. et al. Porous silicon as a versatile platform for laser desorption/ionization mass spectrometry, Anal. Chem., 73(3), 612, 2001.
66. Wei, J., Buriak, J.M., and Siuzdak, G., Desorption-ionization mass spectrometry on porous silicon, Nature, 399, 243, 1999.
67. Cuiffi, J.D. et al. Desorption-ionization mass spectrometry using deposited nanostructured silicon films, Anal. Chem., 73(6), 1292, 2001.
68. Guo, Z. et al. A method for the analysis of low-mass molecules by MALDI-TOF mass spectrometry, Anal. Chem., 74, 1637, 2002.
69. Corr, J.J. et al. MALDI MS/MS on a triple quadrupole mass spectrometer: A new technology for high throughput small molecule quantitation, In Proc. 51st ASMS Conference, Montreal, Quebec, Canada, 2003.
70. Reyzer, M.L. et al. Parallel monitoring of protein and drug expression in tissues by MALDI MS, In Proc. 51st ASMS Conference, Montreal, Quebec, Canada, 2003.
71. Hidalgo, M. et al. Phase I and pharmacologic study of OSI-774, and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies, J. Clin. Oncol., 19(13), 3267, 2001.